You are correct as I phrased it totally incorrectly. The market not thrilled about those 1st quarter sales, but sales were only for a portion of the quarter.
Hopefully we find out more in the earnings call. But, as a small company they may exhibit a similar dynamic, namely having a harder time to ramp sales like a BP would.
Their drug is best in class so sooner later it will catch wind under its sails.
News 
Market Data 
Discover 
AI
